Identification of differentially expressed genes contributing to radioresistance in lung cancer cells using microarray analysis

Radiation Research

Volumn 164, Issue 1, 2005, Pages 27-35

  Guo, Wan Feng ^a,b   Lin, Ru Xian ^a   Huang, Jian ^a   Zhou, Zhe ^a   Yang, Jing ^a   Guo, Guo Zheng ^b   Wang, Sheng Qi ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE;

APOPTOSIS; ARTICLE; BCL2 GENE; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA MICROARRAY; DNA REPAIR; DOWN REGULATION; ERCC1 GENE; ERCC4 GENE; ERCC5 GENE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IONIZING RADIATION; LUNG CANCER; MDM GENE; NUCLEOTIDE SEQUENCE; PIM2 GENE; PKCZ GENE; PRIORITY JOURNAL; RAD9A GENE; RADIATION DOSE; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; XRCC GENE;

CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RADIATION DOSAGE; RADIATION TOLERANCE; RADIATION, IONIZING;

EID: 21244460339     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3401     Document Type: Article

References (38)

1. K. J. Isselbacher, E. Braunwald, J. D. Wilson, J. B. Martin, A. S. Fauci and D. L. Kasper, Neoplasms of the lung. In Harrison's Principles of Internal Medicine, pp. 1221-1229. New York, McGraw-Hill, 1994.
2. J. Dunst, Role of radiotherapy in small cell lung cancer. Lung Cancer 33 (Suppl. 1), S137-S141 (2001).
3. S. Lehnert, Prediction of tumor response to therapy: Molecular markers and the microenvironment. Apoptosis and chips: An overview of the proceedings. Radiat. Res. 154, 121-124 (2000).
4. T. Joki, R. S. Carroll, I. F. Dunn, J. Zhang, T. Abe and P. M. Black, Assessment of alterations in gene expression in recurrent malignant glioma after radiotherapy using complementary deoxoyribonucleic acid microarrays. Neurosurgery 48, 195-201 (2001).
5. E. M. Rosen, S. Fan, S. Rockwell and I. D. Goldberg, The molecular and cellular basis of radiosensitivity: Implications for understanding how normal tissues and tumors respond to therapeutic radiation. Cancer Invest 17, 56-72 (1999).
6. Z. Li, L. Xia, L. M. Lee, A. Khaletzkiy, J. Y. C. Wong and J. J. Li, Effector genes altered in human breast cancer MCF-7 cells following fractionated ionizing radiation. Radiat. Res. 155, 543-553 (2001).
7. X. F. Chen, B. H. Shen, L. Q. Xia, A. Khaletzkiy, D. Chu, J. Y. C. Wong and J. J. Li, Activation of nuclear factor kappaB in radioresistance of TP53-inactive human keratinocytes. Cancer Res. 62, 1213-1221 (2002).
8. G. Z. Guo, Y. S. Yan, B. D. Lyn-cook, T. L. Wang, D. Tame, J. Ogi, A. Khaletskiy, Z. L. Li, C. Weydert and J. J. Li, Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses. Mol. Cell. Biol. 23, 2362-2378 (2003).
9. S. A. Amundson, M. Bittner, P. Meltzer, J. Trent and A. Fornace, Jr., Induction of gene expression as a monitor of exposure to ionizing radiation. Radiat. Res. 156, 657-661 (2001).
10. C. M. Kang, K. P. Park, J. E. Song, D. I. Jeoung, C. K. Cho, T. H. Kim, S. W. Bae, S. J. Lee and Y. S. Lee, Possible biomarkers for ionizing radiation exposure in human peripheral blood lymphocytes. Radiat. Res. 159, 312-319 (2003).
11. W. J. Li, J. Huang, M. Fan and S. Q. Wang, Mprobe: Computer aided probe design for oligonucleotide microarrays. Appl. Bioinformatics 1, 163-166 (2002).
12. A. M. Chalk and E. L. Sonnhammer, Computational antisense oligo prediction with a neural network model. Bioinformatics 18, 1567-1575 (2002).
13. S. T. Cooke, Molecular mechanisms of action of antisense drugs. Biochim. Biophys. Acta 1489, 31-44 (1999).
14. L. Chen, S. Agrawal, W. Zhou, R. Zhang and J. Chen, Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage. Proc. Natl. Acad. Sci. USA 95, 195-200 (1998).
15. N. Sato, K. Mizumoto, N. Maehara, M. Kusumoto, S. Nishio, T. Urashima, T. Ogawa and M. Tanaka, Enhancement of drug-induced apoptosis by antisense oligodeoxynucleotides targeted against Mdm2 and p21WAF1/CIP1. Anticancer Res. 20, 837-842 (2000).
16. S. H. Kim, J. H. Kim and B. Djordjevic, Effects of X-irradiation on RNA and protein synthesis in HeLa cells. Radiat. Res. 42, 577-589 (1970).
17. G. M. Wahl and A. M. Carr, The evolution of diverse biological responses to DNA damage: Insights from yeast and p53. Nat. Cell Biol. 3, E277-E286 (2001).
18. N. F. Lowndes and J. R. Murguia, Sensing and responding to DNA damage. Curr. Opin. Genet. Dev. 10, 17-25 (2000).
19. A. Maity, G. McKenna and R. Muschel, The molecular basis for cell cycle delays following ionizing radiation: A review. Radiother. Oncol. 31, 1-13 (1994).
20. A. G. Paulovich, D. P. Toczynski and G. H. Hartwell, When checkpoints fail. Cell 88, 315-321 (1997).
21. N. Maitland, J. Falck, C. Lukas, R. G. Syljuasen, M. Welcker, J. Bartek and J. Lukas. Rapid destruction of human Cdc25A in response to DNA damage. Science 288, 1425-1429 (2000).
22. K. Galaktionov and D. Beach, Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: Evidence for multiple roles of mitotic cyclins. Cell 67, 1181-1194 (1991).
23. 2 arrests through Cdc25A degradation in response to DNA-damaging agents. J. Biol. Chem. 278, 21767-21773 (2003).
24. 2 checkpoints. Proc. Natl. Acad. Sci. USA 99, 14795-14800 (2002).
25. D. W. Voehringer, D. L. Hirschberg, J. Xiao, Q. Lu, M. Roederer, C. B. Lock, L. A. Herzenberg, L. Steinman and L. A. Herzenberg, Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis. Proc. Natl. Acad. Sci. USA 97, 2680-2685 (2000).
26. W. H. Hu, H. Johnson and H. B. Shu, Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-κB and JNK activation and apoptosis through distinct pathways. J. Biol. Chem. 274, 30603-30610 (1999).
27. B. Gong and A. Almasan, Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells. Cancer Res. 60, 5754-5760 (2000).
28. A. P. Bruno, D. Lautier, A. T. d'Orgeix, G. Laurent and A. Quillet-Mary, Acute myeloblastic leukemic cells acquire cellular cytotoxicity under genotoxic stress: Implication of granzyme B and perforin. Blood 96, 1914-1920 (2000).
29. I. S. Coping, M. Barry, P. Liston, T. Sawchuk, G. Constantinescu, K. M. Michalak, I. Shostak, D. L. Roberts, A. M. Hunter and R. C. Bleackley, Granzyme B-induced apoptosis requires both direct caspase activation and relief of caspase inhibition. Immunity 18, 355-365 (2003).
30. V. R. Sutton, M. E. Wowk, M. Cancilla and J. A. Trapani, Caspase activation by granzyme B is indirect, and caspase autoprocessing requires the release of proapoptotic mitochondrial factors. Immunity 18, 319-329 (2003).
31. T. Yamamoto, K. Yoneda, E. Ueta, S. Doi and T. Osaki, Enhanced apoptosis of squamous cell carcinoma cells by interleukin-2-activated cytotoxic lymphocytes combined with radiation and anticancer drugs. Eur. J. Cancer 36, 2007-2017 (2000).
32. K. O. Tan, K. M. Tan, S. L. Chan, K. S. Yee, M. Bevort, K. C. Ang and V. C. Yu, MAP-1, a novel proapoptotic protein containing a BH3-like motif that associates with Bax through its Bcl-2 homology domains. J. Biol. Chem. 276, 2802-2807 (2001).
33. T. Chittenden, E. A. Harrington, R. O'Connor, C. Flemington, R. J. Lutz, G. I. Evan and B. C. Guild, Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374, 733-736 (1995).
34. M. C. Wei, W. X. Zong, E. H. Cheng, T. Lindsten, V. Panoutsakopoulou, A. J. Ross, K. A. Roth, G. R. MacGregor, C. B. Thompson and S. J. Korsmeyer, Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science 292, 727-730 (2001).
35. M. E. Perry, Mdm2 in the response to radiation. Mol. Cancer Res. 2, 9-19 (2004).
36. X. Wu, J. H. Bayle, D. Olson and A. J. Levine, The p53-mdm2 autoregulatory feedback loop. Genes Dev. 7, 1126-1132 (1993).
37. U. Grunbaum, A. Meye, M. Bache, F. Bartel, P. Wurl, H. Schmidt, J. Dunst and H. Taubert, Transfection with mdm2-antisense or wtp53 results in radiosensitization and an increased apoptosis of a soft tissue sarcoma cell line. Anticancer Res. 21, 2065-2071 (2001).
38. P. Chene, Inhibiting the p53-Mdm2 interaction: an important target for cancer therapy. Nat. Rev. Cancer 3, 102-109 (2003).